TickerFactsScreenerDevelopers

Serina Therapeutics, Inc. (SER) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2016: $259.0K2017: $7.38M2018: $6.71M2019: $2.35M2020: $527.0K2021: $584.0K2022: $645.0K2023: $7.62M2024: $3.67M2025: $3.06M$3.06M
2016Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$3.06M-16.8%
2024$3.67M-51.8%
2023$7.62M+1081.2%
2022$645.0K+10.4%
2021$584.0K+10.8%
2020$527.0K-77.6%
2019$2.35M-64.9%
2018$6.71M-9.1%
2017$7.38M+2747.5%
2016$259.0K—